Amr Soliman to Neoplasm Staging
This is a "connection" page, showing publications Amr Soliman has written about Neoplasm Staging.
Connection Strength
1.526
-
Yang K, Msami K, Calixte R, Mwaiselage J, Dorn J, Soliman AS. Educational Opportunities for Down-Staging Breast Cancer in Low-Income Countries: an Example from Tanzania. J Cancer Educ. 2019 Dec; 34(6):1225-1230.
Score: 0.584
-
Mattick LJ, Ochs-Balcom HM, Mwaiselage J, Kahesa C, Gard AC, Shalan F, Soliman AS. Downstaging of cervical cancer in Tanzania over a 16-year period. Cancer Causes Control. 2021 Apr; 32(4):401-407.
Score: 0.159
-
Trejo MJ, Lishimpi K, Kalima M, Mwaba CK, Banda L, Chuba A, Chama E, Msadabwe SC, Bell ML, Harris RB, Jacobs E, Soliman A. Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia. Int J Gynecol Cancer. 2020 05; 30(5):613-618.
Score: 0.149
-
Alyabsi M, Charlton M, Meza J, Islam KMM, Soliman A, Watanabe-Galloway S. The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population. BMC Health Serv Res. 2019 Mar 18; 19(1):172.
Score: 0.139
-
Elzarkaa AA, Sabaa BE, Abdelkhalik D, Mansour H, Melis M, Shaalan W, Farouk M, Malik E, Soliman AA. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study. J Cancer Res Clin Oncol. 2016 May; 142(5):949-58.
Score: 0.112
-
Refky B, Kotb S, Fady T, Marwan A, Abd El-Khalek D, Elnahas W, Hafez MT, Malik E, Soliman AA. Impact of liver cirrhosis due to chronic hepatitis C viral infection on the outcome of ovarian cancer: a prospective study. BMC Cancer. 2015 Oct 21; 15:754.
Score: 0.110
-
Kalima M, Lishimpi K, Meza JL, Watanabe-Galloway S, Msadabwe SC, Mwaba CK, Shibemba AL, Banda L, Wood C, Chamberlain RM, Soliman AS. Observed and expected incidence of cervical cancer in lusaka and the southern and Western provinces of Zambia, 2007 to 2012. Int J Gynecol Cancer. 2015 Jan; 25(1):98-105.
Score: 0.104
-
Sherr HR, Soliman AS, Bertrand KA, Hirko KA. Persistent poverty and late-stage breast cancer diagnosis in the USA: impacts of rural residence, race, and time within Surveillance, Epidemiology, and End Results registries, 2004 to 2021. Cancer Causes Control. 2025 Nov; 36(11):1589-1597.
Score: 0.054
-
Akinyemiju TF, Soliman AS, Copeland G, Banerjee M, Schwartz K, Merajver SD. Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources. PLoS One. 2013; 8(4):e61879.
Score: 0.023
-
Schlichting JA, Soliman AS, Schairer C, Schottenfeld D, Merajver SD. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008. Breast Cancer Res Treat. 2012 Aug; 134(3):1257-68.
Score: 0.022
-
Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, Dey S, Merajver SD. Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Dis. 2010; 31(1):33-41.
Score: 0.018
-
Fedewa SA, Soliman AS, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Nriagu J, Wilson ML. Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiol. 2009 Oct; 33(3-4):176-81.
Score: 0.018
-
Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat. 2010 Feb; 120(1):149-60.
Score: 0.018
-
Hensley Alford S, Schwartz K, Soliman A, Johnson CC, Gruber SB, Merajver SD. Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women. Breast Cancer Res Treat. 2009 Mar; 114(2):339-46.
Score: 0.016